Company intelligence / Profile preview

Neumitra

Boston, Massachusetts, United Statespmc.ncbi.nlm.nih.gov ↗

Ownership: Private
Development stage: Commercial

Overview

Neumitra developed wearable biomodules ("neuma biowatch") that continuously measure autonomic nervous system signals such as heart rate, skin conductance, temperature, and physical activity. The device aimed to provide a validated stress score for real-time brain health management. The company targeted both consumers and institutional clients but appears to have ceased operations ("Dead" per CB Insights).

No clinical trial results are reported; the product was marketed as a wellness/health analytics tool rather than a regulated medical device.

The technology was licensed to watch and jewelry manufacturers.

Therapeutic areas: PsychiatryCardiovascularNeurology
Modalities: DeviceNon-pharmacological therapy
Industry: Physiological Monitoring

Beyond the preview

Go deeper on Neumitra.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neumitra.

Explore the full profile